Advancing lipid nanoparticle development with structure-based modeling platform and services

Lipid nanoparticle (LNP) technology underlies many modern therapeutics, but understanding how LNP composition drives structural and behavioral variation remains difficult. Schrodinger's computational modeling platform is offered to characterize LNP internal/surface structure and pH dependence, predict apparent pKa of ionizable lipids (a key property for LNP performance), simulate passive and active LNP targeting, and model endosomal escape to improve translation efficiency, including simulating the transition of mRNA from being dispersed within the LNP at low pH to localizing in a bleb at high pH. This page describes the platform's general technical capabilities as a service offering rather than a specific client's results -- it contains no quantitative outcomes or named customer implementation.

The customer is anonymised in Schrödinger’s own case study — not withheld by us.

Schrödinger is a physics-plus-machine-learning computational platform for molecular design; all top-20 pharma companies by revenue are customers of its drug-discovery software.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.